Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2016

Open Access 01-12-2016 | Research

Microarray data analysis to identify crucial genes regulated by CEBPB in human SNB19 glioma cells

Authors: Chenghua Du, Pan Pan, Yan Jiang, Qiuli Zhang, Jinsuo Bao, Chang Liu

Published in: World Journal of Surgical Oncology | Issue 1/2016

Login to get access

Abstract

Background

Glioma is one of the most common primary malignancies in the brain or spine. The transcription factor (TF) CCAAT/enhancer binding protein beta (CEBPB) is important for maintaining the tumor initiating capacity and invasion ability. To investigate the regulation mechanism of CEBPB in glioma, microarray data GSE47352 was analyzed.

Methods

GSE47352 was downloaded from Gene Expression Omnibus, including three samples of SNB19 human glioma cells transduced with non-target control small hairpin RNA (shRNA) lentiviral vectors for 72 h (normal glioma cells) and three samples of SNB19 human glioma cells transduced with CEBPB shRNA lentiviral vectors for 72 h (CEBPB-silenced glioma cells). The differentially expressed genes (DEGs) were screened using limma package and then annotated. Afterwards, the Database for Annotation, Visualization, and Integrated Discovery (DAVID) software was applied to perform enrichment analysis for the DEGs. Furthermore, the protein-protein interaction (PPI) network and transcriptional regulatory network were constructed using Cytoscape software.

Results

Total 529 DEGs were identified in the normal glioma cells compared with the CEBPB-silenced glioma cells, including 336 up-regulated and 193 down-regulated genes. The significantly enriched pathways included chemokine signaling pathway (which involved CCL2), focal adhesion (which involved THBS1 and THBS2), TGF-beta signaling pathway (which involved THBS1, THBS2, SMAD5, and SMAD6) and chronic myeloid leukemia (which involved TGFBR2 and CCND1). In the PPI network, CCND1 (degree = 29) and CCL2 (degree = 12) were hub nodes. Additionally, CEBPB and TCF12 might function in glioma through targeting others (CEBPB → TCF12, CEBPB → TGFBR2, and TCF12 → TGFBR2).

Conclusions

CEBPB might act in glioma by regulating CCL2, CCND1, THBS1, THBS2, SMAD5, SMAD6, TGFBR2, and TCF12.
Literature
1.
go back to reference Mei P, Bai J, Shi M, Liu Q, Li Z, Fan Y, Zheng J. BRMS1 suppresses glioma progression by regulating invasion. Migration and adhesion of glioma cells. PLoS One. 2014;9:e98544.CrossRefPubMedPubMedCentral Mei P, Bai J, Shi M, Liu Q, Li Z, Fan Y, Zheng J. BRMS1 suppresses glioma progression by regulating invasion. Migration and adhesion of glioma cells. PLoS One. 2014;9:e98544.CrossRefPubMedPubMedCentral
3.
go back to reference Onishi M, Ichikawa T, Kurozumi K, Date I. Angiogenesis and invasion in glioma. Brain Tumor Pathol. 2011;28:13–24.CrossRefPubMed Onishi M, Ichikawa T, Kurozumi K, Date I. Angiogenesis and invasion in glioma. Brain Tumor Pathol. 2011;28:13–24.CrossRefPubMed
4.
go back to reference Reuss D, von Deimling A. Hereditary tumor syndromes and gliomas. In: Gliomas. Heidelberg: Springer Berlin; 2009. p. 83-102. Reuss D, von Deimling A. Hereditary tumor syndromes and gliomas. In: Gliomas. Heidelberg: Springer Berlin; 2009. p. 83-102.
5.
go back to reference Cancer IAfRo. IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to humans. Lyon: World Health Organization; 2011. Cancer IAfRo. IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to humans. Lyon: World Health Organization; 2011.
6.
go back to reference Fahmideh MA, Schwartzbaum J, Frumento P, Feychting M. Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis. Neuro Oncol. 2014;16:807–14.CrossRef Fahmideh MA, Schwartzbaum J, Frumento P, Feychting M. Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis. Neuro Oncol. 2014;16:807–14.CrossRef
7.
go back to reference Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9:157–73.CrossRefPubMed Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9:157–73.CrossRefPubMed
8.
go back to reference Tso C-L, Shintaku P, Chen J, Liu Q, Liu J, Chen Z, Yoshimoto K, Mischel PS, Cloughesy TF, Liau LM. Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res. 2006;4:607–19.CrossRefPubMed Tso C-L, Shintaku P, Chen J, Liu Q, Liu J, Chen Z, Yoshimoto K, Mischel PS, Cloughesy TF, Liau LM. Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res. 2006;4:607–19.CrossRefPubMed
9.
go back to reference Singh R, Sharma MC, Sarkar C, Singh M, Chauhan SS. Transcription factor C/EBP-β mediates downregulation of dipeptidyl-peptidase III expression by interleukin-6 in human glioblastoma cells. FEBS J. 2014;281:1629–41.CrossRefPubMed Singh R, Sharma MC, Sarkar C, Singh M, Chauhan SS. Transcription factor C/EBP-β mediates downregulation of dipeptidyl-peptidase III expression by interleukin-6 in human glioblastoma cells. FEBS J. 2014;281:1629–41.CrossRefPubMed
10.
go back to reference Aguilarmorante D, Moralesgarcia JA, Santos A, Perezcastillo A. CCAAT/enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4. Oncotarget. 2015;6:454–63. Aguilarmorante D, Moralesgarcia JA, Santos A, Perezcastillo A. CCAAT/enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4. Oncotarget. 2015;6:454–63.
11.
go back to reference Okano K, Hibi A, Miyaoka T, Inoue T, Sugimoto H, Tsuchiya K, Akiba T, Nitta K. Inhibitory effects of the transcription factor Ets-1 on the expression of type I collagen in TGF-β1-stimulated renal epithelial cells. Mol Cell Biochem. 2012;369:247–54.CrossRefPubMed Okano K, Hibi A, Miyaoka T, Inoue T, Sugimoto H, Tsuchiya K, Akiba T, Nitta K. Inhibitory effects of the transcription factor Ets-1 on the expression of type I collagen in TGF-β1-stimulated renal epithelial cells. Mol Cell Biochem. 2012;369:247–54.CrossRefPubMed
12.
go back to reference Barnes JM, Weaver VM. Abstract B04: the role of mechanical force and integrin-ECM signaling in glioblastoma aggression. Cancer Res. 2013;73:B04.CrossRef Barnes JM, Weaver VM. Abstract B04: the role of mechanical force and integrin-ECM signaling in glioblastoma aggression. Cancer Res. 2013;73:B04.CrossRef
13.
14.
go back to reference Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H. The transcriptional network for mesenchymal transformation of brain tumours. Nature. 2009;463:318–25.CrossRefPubMedPubMedCentral Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H. The transcriptional network for mesenchymal transformation of brain tumours. Nature. 2009;463:318–25.CrossRefPubMedPubMedCentral
15.
go back to reference Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.CrossRefPubMedPubMedCentral Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.CrossRefPubMedPubMedCentral
16.
go back to reference Ghosh D. Incorporating the empirical null hypothesis into the Benjamini-Hochberg procedure. Stat Appl Genet Mol Biol. 2012;11:1–21. Ghosh D. Incorporating the empirical null hypothesis into the Benjamini-Hochberg procedure. Stat Appl Genet Mol Biol. 2012;11:1–21.
17.
go back to reference Consortium GO. Gene ontology consortium: going forward. Nucleic Acids Res. 2015;43:1049–56.CrossRef Consortium GO. Gene ontology consortium: going forward. Nucleic Acids Res. 2015;43:1049–56.CrossRef
18.
go back to reference Du J, Yuan Z, Ma Z, Song J, Xie X, Chen Y. KEGG-PATH: Kyoto encyclopedia of genes and genomes-based pathway analysis using a path analysis model. Mol Biosyst. 2014;10:2441–7.CrossRefPubMed Du J, Yuan Z, Ma Z, Song J, Xie X, Chen Y. KEGG-PATH: Kyoto encyclopedia of genes and genomes-based pathway analysis using a path analysis model. Mol Biosyst. 2014;10:2441–7.CrossRefPubMed
19.
go back to reference Jiao X, Sherman BT, Huang DW, Stephens R, Baseler MW, Lane HC, Lempicki RA. DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics. 2012;28:1805–6.CrossRefPubMedPubMedCentral Jiao X, Sherman BT, Huang DW, Stephens R, Baseler MW, Lane HC, Lempicki RA. DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics. 2012;28:1805–6.CrossRefPubMedPubMedCentral
20.
go back to reference Zhao M, Sun J, Zhao Z. TSGene: a web resource for tumor suppressor genes. Nucleic Acids Res. 2013;41:D970–6.CrossRefPubMed Zhao M, Sun J, Zhao Z. TSGene: a web resource for tumor suppressor genes. Nucleic Acids Res. 2013;41:D970–6.CrossRefPubMed
21.
go back to reference Chen J-S, Hung W-S, Chan H-H, Tsai S-J, Sun HS. In silico identification of oncogenic potential of fyn-related kinase in hepatocellular carcinoma. Bioinformatics. 2013;29:420–7.CrossRefPubMed Chen J-S, Hung W-S, Chan H-H, Tsai S-J, Sun HS. In silico identification of oncogenic potential of fyn-related kinase in hepatocellular carcinoma. Bioinformatics. 2013;29:420–7.CrossRefPubMed
22.
go back to reference Raney BJ, Cline MS, Rosenbloom KR, Dreszer TR, Learned K, Barber GP, Meyer LR, Sloan CA, Malladi VS, Roskin KM, et al. ENCODE whole-genome data in the UCSC genome browser (2011 update). Nucleic Acids Res. 2011;39:30.CrossRef Raney BJ, Cline MS, Rosenbloom KR, Dreszer TR, Learned K, Barber GP, Meyer LR, Sloan CA, Malladi VS, Roskin KM, et al. ENCODE whole-genome data in the UCSC genome browser (2011 update). Nucleic Acids Res. 2011;39:30.CrossRef
23.
go back to reference Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C. STRING v9. 1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41:D808–15.CrossRefPubMed Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C. STRING v9. 1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41:D808–15.CrossRefPubMed
24.
go back to reference Saito R, Smoot ME, Ono K, Ruscheinski J, Wang P-L, Lotia S, Pico AR, Bader GD, Ideker T. A travel guide to Cytoscape plugins. Nat Methods. 2012;9:1069–76.CrossRefPubMedPubMedCentral Saito R, Smoot ME, Ono K, Ruscheinski J, Wang P-L, Lotia S, Pico AR, Bader GD, Ideker T. A travel guide to Cytoscape plugins. Nat Methods. 2012;9:1069–76.CrossRefPubMedPubMedCentral
25.
go back to reference Chao W, Zhu J, Zhang X. Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genes. BMC Bioinf. 2012;13:1–10.CrossRef Chao W, Zhu J, Zhang X. Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genes. BMC Bioinf. 2012;13:1–10.CrossRef
26.
go back to reference Domanska UM, Kruizinga RC, Dunnen WFAD, Timmer-Bosscha H, Vries EGED, Walenkamp AME. The chemokine network, a newly discovered target in high grade gliomas. Crit Rev Oncol Hematol. 2011;79:154–63.CrossRefPubMed Domanska UM, Kruizinga RC, Dunnen WFAD, Timmer-Bosscha H, Vries EGED, Walenkamp AME. The chemokine network, a newly discovered target in high grade gliomas. Crit Rev Oncol Hematol. 2011;79:154–63.CrossRefPubMed
27.
go back to reference Carrillo-de Sauvage MA, Gómez A, Ros CM, Ros-Bernal F, Martín ED, Perez-Vallés A, Gallego-Sanchez JM, Fernández-Villalba E, Sr BC, Jr BC. CCL2-expressing astrocytes mediate the extravasation of T lymphocytes in the brain. Evidence from patients with glioma and experimental models in vivo. PLoS One. 2012;7:e30762.CrossRefPubMedPubMedCentral Carrillo-de Sauvage MA, Gómez A, Ros CM, Ros-Bernal F, Martín ED, Perez-Vallés A, Gallego-Sanchez JM, Fernández-Villalba E, Sr BC, Jr BC. CCL2-expressing astrocytes mediate the extravasation of T lymphocytes in the brain. Evidence from patients with glioma and experimental models in vivo. PLoS One. 2012;7:e30762.CrossRefPubMedPubMedCentral
28.
go back to reference Lindemann C, Marschall V, Weigert A, Klingebiel T, Fulda S. Smac mimetic-induced upregulation of CCL2/MCP-1 triggers migration and invasion of glioblastoma cells and influences the tumor microenvironment in a paracrine manner 1. Neoplasia. 2015;17:481–9.CrossRefPubMedPubMedCentral Lindemann C, Marschall V, Weigert A, Klingebiel T, Fulda S. Smac mimetic-induced upregulation of CCL2/MCP-1 triggers migration and invasion of glioblastoma cells and influences the tumor microenvironment in a paracrine manner 1. Neoplasia. 2015;17:481–9.CrossRefPubMedPubMedCentral
29.
go back to reference Könnecke H, Bechmann I. The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas. Clin Dev Immunol. 2013;2013:914104.CrossRefPubMedPubMedCentral Könnecke H, Bechmann I. The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas. Clin Dev Immunol. 2013;2013:914104.CrossRefPubMedPubMedCentral
30.
go back to reference Roth P, Silginer M, Goodman SL, Hasenbach K, Thies S, Maurer G, Schraml P, Tabatabai G, Moch H, Tritschler I. Integrin control of the transforming growth factor-β pathway in glioblastoma. Brain. 2013;136:564–76.CrossRefPubMed Roth P, Silginer M, Goodman SL, Hasenbach K, Thies S, Maurer G, Schraml P, Tabatabai G, Moch H, Tritschler I. Integrin control of the transforming growth factor-β pathway in glioblastoma. Brain. 2013;136:564–76.CrossRefPubMed
31.
go back to reference Seliger C, Leukel P, Moeckel S, Jachnik B, Lottaz C, Kreutz M, Brawanski A, Proescholdt M, Bogdahn U, Bosserhoff A-K. Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitro. PLoS One. 2013;8:e78935.CrossRefPubMedPubMedCentral Seliger C, Leukel P, Moeckel S, Jachnik B, Lottaz C, Kreutz M, Brawanski A, Proescholdt M, Bogdahn U, Bosserhoff A-K. Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitro. PLoS One. 2013;8:e78935.CrossRefPubMedPubMedCentral
32.
go back to reference Brooks MD, Jackson E, Piwnica-Worms D, Mitre RD, Rubin JB. Downregulation of THBS1 is a critical step in glioblastoma angiogenesis. In: Cancer research. Philadelphia: AMER Assoc Cancer Research; 2013. Brooks MD, Jackson E, Piwnica-Worms D, Mitre RD, Rubin JB. Downregulation of THBS1 is a critical step in glioblastoma angiogenesis. In: Cancer research. Philadelphia: AMER Assoc Cancer Research; 2013.
33.
go back to reference Hawighorst T, Velasco P, Streit M, Hong YK, Kyriakides TR, Brown LF, Bornstein P, Detmar M. Thrombospondin‐2 plays a protective role in multistep carcinogenesis: a novel host anti‐tumor defense mechanism. EMBO J. 2001;20:2631–40.CrossRefPubMedPubMedCentral Hawighorst T, Velasco P, Streit M, Hong YK, Kyriakides TR, Brown LF, Bornstein P, Detmar M. Thrombospondin‐2 plays a protective role in multistep carcinogenesis: a novel host anti‐tumor defense mechanism. EMBO J. 2001;20:2631–40.CrossRefPubMedPubMedCentral
34.
35.
go back to reference Jarjour AA, Durko M, Luk TL, Marçal N, Shekarabi M, Kennedy TE. Autocrine netrin function inhibits glioma cell motility and promotes focal adhesion formation. PLoS One. 2011;6:e25408.CrossRefPubMedPubMedCentral Jarjour AA, Durko M, Luk TL, Marçal N, Shekarabi M, Kennedy TE. Autocrine netrin function inhibits glioma cell motility and promotes focal adhesion formation. PLoS One. 2011;6:e25408.CrossRefPubMedPubMedCentral
36.
go back to reference Jung SM, Lee JH, Park J, Oh YS, Lee SK, Park JS, Lee YS, Kim JH, Lee JY, Bae YS, et al. Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6. Nat Commun. 2013;4:2562.PubMed Jung SM, Lee JH, Park J, Oh YS, Lee SK, Park JS, Lee YS, Kim JH, Lee JY, Bae YS, et al. Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6. Nat Commun. 2013;4:2562.PubMed
38.
go back to reference Phull P, Shipley A, Mowat N. NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFR. PLoS One. 2013;8:271–2. Phull P, Shipley A, Mowat N. NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFR. PLoS One. 2013;8:271–2.
39.
go back to reference Rožmarić M, Ivšić AG, Grahek Ž. TGF-beta induced Erk phosphorylation of smad linker region regulates smad signaling. PLoS One. 2012;7:2016. Rožmarić M, Ivšić AG, Grahek Ž. TGF-beta induced Erk phosphorylation of smad linker region regulates smad signaling. PLoS One. 2012;7:2016.
40.
go back to reference Wesolowska A, Kwiatkowska A, Slomnicki L, Dembinski M, Master A, Sliwa M, Franciszkiewicz K, Chouaib S, Kaminska B. Microglia-derived TGF-β as an important regulator of glioblastoma invasion—an inhibition of TGF-β-dependent effects by shRNA against human TGF-β type II receptor. Oncogene. 2007;27:918–30.CrossRefPubMed Wesolowska A, Kwiatkowska A, Slomnicki L, Dembinski M, Master A, Sliwa M, Franciszkiewicz K, Chouaib S, Kaminska B. Microglia-derived TGF-β as an important regulator of glioblastoma invasion—an inhibition of TGF-β-dependent effects by shRNA against human TGF-β type II receptor. Oncogene. 2007;27:918–30.CrossRefPubMed
41.
go back to reference Fuxe J, Vincent T, Garcia de Herreros A. Transcriptional crosstalk between TGF-beta and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle. 2010;9:2363–74.CrossRefPubMed Fuxe J, Vincent T, Garcia de Herreros A. Transcriptional crosstalk between TGF-beta and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle. 2010;9:2363–74.CrossRefPubMed
42.
go back to reference Bae E, Kim S-J, Hong S, Liu F, Ooshima A. Smad3 linker phosphorylation attenuates Smad3 transcriptional activity and TGF-β1/Smad3-induced epithelial-mesenchymal transition in renal epithelial cells. Biochem Biophys Res Commun. 2012;427:593–9.CrossRefPubMed Bae E, Kim S-J, Hong S, Liu F, Ooshima A. Smad3 linker phosphorylation attenuates Smad3 transcriptional activity and TGF-β1/Smad3-induced epithelial-mesenchymal transition in renal epithelial cells. Biochem Biophys Res Commun. 2012;427:593–9.CrossRefPubMed
43.
go back to reference Lee CC, Chen WS, Chen CC, Chen LL, Lin YS, Fan CS, Huang TS. TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer. J Biol Chem. 2011;287:2798–809.CrossRefPubMedPubMedCentral Lee CC, Chen WS, Chen CC, Chen LL, Lin YS, Fan CS, Huang TS. TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer. J Biol Chem. 2011;287:2798–809.CrossRefPubMedPubMedCentral
Metadata
Title
Microarray data analysis to identify crucial genes regulated by CEBPB in human SNB19 glioma cells
Authors
Chenghua Du
Pan Pan
Yan Jiang
Qiuli Zhang
Jinsuo Bao
Chang Liu
Publication date
01-12-2016
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2016
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-016-0997-z

Other articles of this Issue 1/2016

World Journal of Surgical Oncology 1/2016 Go to the issue